Serotonin and its 5-HT1 receptor in human mastocytosis

References

• Arock, M., Valent, P. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert Rev Hematol 2010, 3, 497–516.
   PubMed Web of Science ®Google Scholar
• Büttner, C., Henz, B.M., Welker, P., Sepp, N.T., Grabbe, J. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol 1998, 111, 1227–1231.
   PubMed Web of Science ®Google Scholar
• Hartmann, K., Hermes, B., Rappersberger, K., Sepp, N., Mekori, Y.A., Henz, B.M. Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis. Br J Dermatol 2003, 149, 554–559.
   PubMed Web of Science ®Google Scholar
• Slominski, A., Pisarchik, A., Semak, I., Sweatman, T., Wortsman, J., Szczesniewski, A., Slugocki, G., McNulty, J., Kauser, S., Tobin, D.J., Jing, C., Johansson, O. Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 2002, 16, 896–898.
   PubMed Web of Science ®Google Scholar
• Slominski, A., Wortsman, J., Tobin, D.J. The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J 2005, 19, 176–194.
   PubMed Web of Science ®Google Scholar
• Edvinsson, L., Cervós-Navarro, J., Larsson, L.I., Owman, C., Rönnberg, A.L. Regional distribution of mast cells containing histamine, dopamine, or 5-hydroxytryptamine in the mammalian brain. Neurology 1977, 27, 878–883.
   PubMed Web of Science ®Google Scholar
• Fröberg, G.K., Lindberg, R., Ritter, M., Nordlind, K. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours. J Comp Pathol 2009, 141, 89–97.
   PubMedGoogle Scholar
• Lefebvre, H., Contesse, V., Delarue, C., Feuilloley, M., Hery, F., Grise, P., Raynaud, G., Verhofstad, A.A., Wolf, L.M., Vaudry, H. Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype. Neuroscience 1992, 47, 999–1007.
   PubMed Web of Science ®Google Scholar
• Zochodne, D.W., Theriault, M., Sharkey, K.A., Cheng, C., Sutherland, G. Peptides and neuromas: calcitonin gene-related peptide, substance P, and mast cells in a mechanosensitive human sural neuroma. Muscle Nerve 1997, 20, 875–880.
   PubMedGoogle Scholar
• Kushnir-Sukhov, N.M., Brown, J.M., Wu, Y., Kirshenbaum, A., Metcalfe, D.D. Human mast cells are capable of serotonin synthesis and release. J Allergy Clin Immunol 2007, 119, 498–499.
   PubMed Web of Science ®Google Scholar
• Hayes, D.J., Greenshaw, A.J. 5-HT receptors and reward-related behaviour: a review. Neurosci Biobehav Rev 2011, 35, 1419–1449.
   PubMed Web of Science ®Google Scholar
• Lundeberg, L., El-Nour, H., Mohabbati, S., Morales, M., Azmitia, E., Nordlind, K. Expression of serotonin receptors in allergic contact eczematous human skin. Arch Dermatol Res 2002, 294, 393–398.
   PubMedGoogle Scholar
• El-Nour, H., Lundeberg, L., Abdel-Magid, N., Lonne-Rahm, S.B., Azmitia, E.C., Nordlind, K. Serotonergic mechanisms in human allergic contact dermatitis. Acta Derm Venereol 2007, 87, 390–396.
   PubMedGoogle Scholar
• Lonne-Rahm, S.B., Rickberg, H., El-Nour, H., Mårin, P., Azmitia, E.C., Nordlind, K. Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress. J Eur Acad Dermatol Venereol 2008, 22, 11–18.
   PubMed Web of Science ®Google Scholar
• Nordlind, K., Thorslund, K., Lonne-Rahm, S., Mohabbati, S., Berki, T., Morales, M., Azmitia, E.C. Expression of serotonergic receptors in psoriatic skin. Arch Dermatol Res 2006, 298, 99–106.
   PubMedGoogle Scholar
• Vicaut, E., Laemmel, E., Stücker, O. Impact of serotonin on tumour growth. Ann Med 2000, 32, 187–194.
   PubMed Web of Science ®Google Scholar
• Siddiqui, E.J., Thompson, C.S., Mikhailidis, D.P., Mumtaz, F.H. The role of serotonin in tumour growth (review). Oncol Rep 2005, 14, 1593–1597.
   PubMedGoogle Scholar
• Abdul, M., Anezinis, P.E., Logothetis, C.J., Hoosein, N.M. Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonists. Anticancer Res 1994, 14, 1215–1220.
   PubMed Web of Science ®Google Scholar
• Dizeyi, N., Bjartell, A., Nilsson, E., Hansson, J., Gadaleanu, V., Cross, N., Abrahamsson, P.A. Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines. Prostate 2004, 59, 328–336.
   PubMed Web of Science ®Google Scholar
• Cattaneo, M.G., Fesce, R., Vicentini, L.M. Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT1A and 5-HT1D receptors. Eur J Pharmacol 1995, 291, 209–211.
   PubMed Web of Science ®Google Scholar
• Pranzatelli, M.R., Balletti, J. Characterization of 5-hydroxytryptamine 1A-like binding sites in human ganglioneuroblastoma. Neurosci Lett 1991, 132, 117–120.
   PubMedGoogle Scholar
• Ishizuka, J., Beauchamp, R.D., Townsend, C.M. Jr, Greeley, G.H. Jr, Thompson, J.C. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J Cell Physiol 1992, 150, 1–7.
   PubMed Web of Science ®Google Scholar
• Soll, C., Jang, J.H., Riener, M.O., Moritz, W., Wild, P.J., Graf, R., Clavien, P.A. Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology 2010, 51, 1244–1254.
   PubMed Web of Science ®Google Scholar
• Azmitia, E.C., Yu, I., Akbari, H.M., Kheck, N., Whitaker-Azmitia, P.M., Marshak, D.R. Antipeptide antibodies against the 5-HT1A receptor. J Chem Neuroanat 1992, 5, 289–298.
   PubMedGoogle Scholar
• DeFelipe, J., Arellano, J.I., Gómez, A., Azmitia, E.C., Muñoz, A. Pyramidal cell axons show a local specialization for GABA and 5-HT inputs in monkey and human cerebral cortex. J Comp Neurol 2001, 433, 148–155.
   PubMedGoogle Scholar
• Sundström, M., Vliagoftis, H., Karlberg, P., Butterfield, J.H., Nilsson, K., Metcalfe, D.D., Nilsson, G. Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene. Immunology 2003, 108, 89–97.
   PubMed Web of Science ®Google Scholar
• Beck, O., Wallén, N.H., Bröijersén, A., Larsson, P.T., Hjemdahl, P. On the accurate determination of serotonin in human plasma. Biochem Biophys Res Commun 1993, 196, 260–266.
   PubMed Web of Science ®Google Scholar
• Slominski, A., Pisarchik, A., Johansson, O., Jing, C., Semak, I., Slugocki, G., Wortsman, J. Tryptophan hydroxylase expression in human skin cells. Biochim Biophys Acta 2003, 1639, 80–86.
   PubMed Web of Science ®Google Scholar
• Azmitia, E.C. Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull 2001, 56, 413–424.
   PubMed Web of Science ®Google Scholar
• Abdouh, M., Albert, P.R., Drobetsky, E., Filep, J.G., Kouassi, E. 5-HT1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-kappaB to the nucleus. Brain Behav Immun 2004, 18, 24–34.
   PubMed Web of Science ®Google Scholar
• Ahlemeyer, B., Krieglstein, J. Stimulation of 5-HT1A receptor inhibits apoptosis induced by serum deprivation in cultured neurons from chick embryo. Brain Res 1997, 777, 179–186.
   PubMed Web of Science ®Google Scholar
• Adayev, T., Ray, I., Sondhi, R., Sobocki, T., Banerjee, P. The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase Calpha. Biochim Biophys Acta 2003, 1640, 85–96.
   PubMed Web of Science ®Google Scholar
• Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J.H., Ashman, L.K., Kanayama, Y. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993, 92, 1736–1744.
   PubMed Web of Science ®Google Scholar
• Kushnir-Sukhov, N.M., Gilfillan, A.M., Coleman, J.W., Brown, J.M., Bruening, S., Toth, M., Metcalfe, D.D. 5-hydroxytryptamine induces mast cell adhesion and migration. J Immunol 2006, 177, 6422–6432.
   PubMedGoogle Scholar
• Oishi, R., Itoh, Y., Saeki, K. Inhibition of histamine turnover by 8-OH-DPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain. Naunyn Schmiedebergs Arch Pharmacol 1992, 345, 495–499.
   PubMedGoogle Scholar